SULT2B1 and malignant colon neoplasm: To sum up, the conclusion of the current study was that OLR1 knockdown disrupted the activation of c-MYC/SULT2B1 axis to repress glycolytic metabolism, thus restraining cell proliferation and chemoresistance in colon cancer.